|
Characteristics of patients treated with 3rd generation cephalosporins at the POSGH |
|
| Characteristics |
No (%) |
|
|
|
| Gender |
|
| Male |
84 (42) |
| Female |
111(58) |
| Age: Mean SD (Range) |
45 ± 20.56(13–90 years) |
| Category of service |
|
| Surgery |
84(43.8) |
| Medicine |
53(27.6) |
| Gynaecology |
29(15.1) |
| Orthopaedics |
24(12.5) |
| Others (CNS, Genital, Septicaemia) |
2 |
| Predisposing Factors |
|
| None |
129(67.2) |
| Diabetes Mellitus |
47(24.5) |
| HIV/AIDS |
9 (4.7) |
| Infection characteristics |
|
| Clinically suspected |
108(56) |
| Clinically absent |
84(44) |
| Site Unknown |
69(35.9) |
| Skin and Soft tissue |
39(20.3) |
| Respiratory tract |
21(10.9) |
| Gastrointestinal tract |
20(10.7) |
| Urinary tract |
18(9.3) |
| Others |
25(13.0) |
| Antibiotic Use |
|
| Prophylactic |
57 (29.7) |
| Empiric |
131(68.2) |
| Therapeutic |
4(2.0) |
| Single drug |
94(49.6) |
| Two or more drugs |
94(49.6) |
| Appropriate |
62(32.3) |
| Inappropriate |
124(64.6) 6(3.1) |
| Undetermined |
|
| Bacteriological Investigations |
|
| Done |
52 (27) |
| Not done |
140 (73) |
Pinto Pereira et al. BMC Infectious Diseases 2004 4:59 doi:10.1186/1471-2334-4-59 |
|